3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Conditions
Fasting
2
Colorectal Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Solitary Fibrous Tumors
1
Sarcoma
1
Liposarcoma
1
Intermittent Fasting
1
Histiocytoma, Malignant Fibrous
1
Fibrosis
1
Esophageal Neoplasms
1
Dermatofibrosarcoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
belinostat
2
sodium thiosulfate
1
sargramostim
1
romidepsin
1
pembrolizumab
1
enzalutamide
1
brostallicin
1
X-Rays
1
Trabectedin
1
Therapeutics
1
Sunitinib
1
Specimen Handling
1
Radiation, Ionizing
1
Quality of Life
1
Platinum
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Midazolam
1
Magnetic Resonance Spectroscopy
1
Letrozole
1
Immunotherapy
1
Imatinib Mesylate
1
Hyperthermic Intraperitoneal Chemotherapy
1
Histamine H2 Antagonists
1
HhAntag691
1
Fulvestrant
1
Fluorouracil
1
Famotidine
1
Drug Therapy
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liposarcoma
×
Angptl4 protein, mouse
×
Gastrointestinal
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled